MARJORIE L. BOWEN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

DIEBOLD NIXDORF, Inc

Filing Date	Source Excerpt
2023-03-16	Ms. Bowen is a member of the Finance Committee. She joined the Board in 2023 and did not receive compensation in 2022.
2024-03-12	Ms. Bowen is a former Managing Director of Houlihan Lokey... Ms. Bowen joined the board of CBL Properties in 2021, where she is currently the chair of the audit committee and a member of the nominations/governance committee. ... DIRECTOR QUALIFICATIONS: Ms. Bowen is an active public company director, and former investment banker. She has served on over a dozen boards of private and public companies following a nearly 20-year career in investment banking and has extensive board experiences with companies undergoing transformations.

Filing Date

Source Excerpt

2023-03-16

Ms. Bowen is a member of the Finance Committee. She joined the Board in 2023 and did not receive compensation in 2022.

2024-03-12

Ms. Bowen is a former Managing Director of Houlihan Lokey... Ms. Bowen joined the board of CBL Properties in 2021, where she is currently the chair of the audit committee and a member of the nominations/governance committee. ... DIRECTOR QUALIFICATIONS: Ms. Bowen is an active public company director, and former investment banker. She has served on over a dozen boards of private and public companies following a nearly 20-year career in investment banking and has extensive board experiences with companies undergoing transformations.

GENESCO INC

Filing Date	Source Excerpt
2018-05-16	MARJORIE L. BOWEN, 53, Retired Managing Director, Houlihan Lokey. Ms. Bowen joined Genesco's board in April 2018. ... The strategic alternatives committee was formed on February 8, 2018, and did not meet during Fiscal 2018. The strategic alternatives committee is currently composed of six directors who are independent under applicable NYSE rules. Its functions are specified in a charter available on the Company's website, www.genesco.com. They include the responsibility to review, evaluate, identify and provide direction concerning acquisitions, dispositions, joint ventures, asset sales or divestitures, and similar strategic alternatives that may enhance shareholder value and that are or may be available to the Company, as well as to exercise any other powers and carry out any other responsibilities delegated to it by the board from time to time.

Filing Date

Source Excerpt

2018-05-16

MARJORIE L. BOWEN, 53, Retired Managing Director, Houlihan Lokey. Ms. Bowen joined Genesco's board in April 2018. ... The strategic alternatives committee was formed on February 8, 2018, and did not meet during Fiscal 2018. The strategic alternatives committee is currently composed of six directors who are independent under applicable NYSE rules. Its functions are specified in a charter available on the Company's website, www.genesco.com. They include the responsibility to review, evaluate, identify and provide direction concerning acquisitions, dispositions, joint ventures, asset sales or divestitures, and similar strategic alternatives that may enhance shareholder value and that are or may be available to the Company, as well as to exercise any other powers and carry out any other responsibilities delegated to it by the board from time to time.

Data sourced from SEC filings. Last updated: 2025-07-01